Screener
Bristol-Myers Squibb BMY Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $3.32B+153% | $2.68B+8.8% | $1.09B— | $2.2B+80.7% | $1.31B-22.0% | ||
| $594M-41.2% | $594M-41.3% | $977M-48.0% | $1.01B-61.0% | $1.01B-61.1% | ||
| $135M-1.5% | $146M+1.4% | $133M+10.8% | $139M+7.8% | $137M+9.6% | ||
| $3.39B-13.4% | $1.1B-43.5% | $1.97B-55.5% | $6.31B+12.9% | $3.92B+68.4% | ||
| $305M-15.5% | $347M+33.5% | $370M-2.1% | $320M-1.2% | $361M+37.8% | ||
| $91M-68.1% | $65M-16.7% | $1.71B+3,532% | $1.87B+439% | $285M-79.2% | ||
| -$1.61B-241% | -$131M+73.7% | -$1.46B-644% | -$1.7B-677% | -$473M+64.1% | ||
| $1.29B+2.0% | $1.28B+2.0% | $1.26B+3.6% | $1.26B+3.9% | $1.26B+3.7% | ||
| $1.22B+89.7% | $500M— | $10.07B— | $229M-90.8% | $643M+62.8% | ||
| -$2.63B-43.2% | -$1.56B-57.1% | -$6.03B— | -$1.49B— | -$1.84B— | ||
| -$861M-150% | -$635M-220% | -$5.51B— | $3.12B— | $1.74B+157% | ||
| $3.09B-13.2% | $757M-55.3% | $1.6B-60.5% | $5.99B+13.7% | $3.56B+72.3% |
FAQ
- How much cash does Bristol-Myers Squibb generate?
- Bristol-Myers Squibb (BMY) generated $12.8B in operating cash flow over the trailing twelve months.
- What is Bristol-Myers Squibb's free cash flow?
- After $1.3B of capital expenditures, Bristol-Myers Squibb's free cash flow was $11.4B over the trailing twelve months, down 21.5% year over year.
- Where does Bristol-Myers Squibb's cash flow data come from?
- Every line is extracted from Bristol-Myers Squibb's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
